𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comorbidity in patients with cancer of the head and neck: Prevalence and impact on treatment and prognosis

✍ Scribed by Jay F. Piccirillo; Anna Vlahiotis

Book ID
107546460
Publisher
Current Science Inc.
Year
2006
Tongue
English
Weight
161 KB
Volume
8
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Differential prognostic impact of comorb
Differential prognostic impact of comorbidity in head and neck cancer
✍ Olli-Pekka Alho; Kalle Hannula; Antti Luokkala; Heikki Teppo; Petri Koivunen; Sa πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 1 views

## Abstract ## Background. The aim was to investigate how the effect of comorbid illnesses on survival is modified by other prognostic factors in head and neck cancer. ## Methods. A population‐based retrospective cohort study involved 221 patients residing in 1 primary health care district (popu

Nutritional support and prognosis in pat
Nutritional support and prognosis in patients with head and neck cancer
✍ Dr. Marvin J. Lopez; Pat Robinson; Tim Madden; Toni Highbarger πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 403 KB

We retrospectively studied the relationship between nutritional status as indicated by the presence or absence of the cutaneous delayed hypersensitivity response and treatment-related morbidity, disease recurrence, and survival at 2 years in 67 consecutive patients with head and neck carcinoma. Seri

Impact of comorbidity on short-term mort
Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients
✍ Frank R. Datema; Marciano B. Ferrier; Marc P. van der Schroeff; Robert J. Baaten πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 178 KB πŸ‘ 1 views

## Abstract ## Background In 2001, we presented a Cox regression model that is able to predict survival of the newly diagnosed patient with head and neck squamous cell carcinoma (HNSCC). This model is based on the TNM classification and other important clinical variables such as age at diagnosis,

Methylphenidate treatment of patients wi
Methylphenidate treatment of patients with head and neck cancer
✍ Fernandez, Francisco ;Adams, Frank πŸ“‚ Article πŸ“… 2006 πŸ› Wiley (John Wiley & Sons) βš– 491 KB πŸ‘ 2 views

Five organically impaired and depressed head and neck cancer patients had a marked therapeutic response to methylphenidate (MPD). There was a rapid remission of depressive and cognitive dysfunctions without adverse side effects. The relationship of cognitive, behavioral, and affective symptoms to br

Impact of comorbidity on outcome of youn
Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma
✍ Bhuvanesh Singh; Mahesh Bhaya; Marc Zimbler; Jordan Stern; J. Thomas Roland; Ric πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 3 views

Background. Comorbid conditions have a significant impact on the actuarial survival of patients with head and neck cancer. However, no studies have evaluated the impact of comorbidity on tumor-and treatment-specific outcomes. This study was performed to evaluate the impact of comorbidity, graded by